雅各臣科研制药(02633)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02633 雅各臣科研制药

未开盘 07-20 15:48:31

1.070

+0.020

+1.90%

最高1.100	最低1.070	成交量55.60万
今开1.070	昨收1.050	日振幅2.86%
总市值21.40亿	流通市值21.40亿	总股本20.00亿
成交额60.20万	换手率0.03%	流通股本20.00亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02633","market":"HK","secType":"STK","nameCN":"雅各臣科研制药","latestPrice":1.07,"timestamp":1784533711402,"preClose":1.05,"halted":0,"volume":556000,"delay":0,"changeRate":0.019047619047619063,"floatShares":2000000000,"shares":2000000000,"eps":0.151484,"marketStatus":"未开盘","change":0.02,"latestTime":"07-20 15:48:31","open":1.07,"high":1.1,"low":1.07,"amount":601980,"amplitude":0.028571,"askPrice":1.07,"askSize":4000,"bidPrice":1.06,"bidSize":14000,"shortable":0,"etf":0,"ttmEps":0.151,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1784597400000},"marketStatusCode":0,"adr":0,"listingDate":1474387200000,"exchange":"SEHK","adjPreClose":1.05,"dividendRate":0.084112,"openAndCloseTimeList":[[1784511000000,1784520000000],[1784523600000,1784534400000]],"volumeRatio":6.043478256271267,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02633","defaultTab":"news","newsList":[{"id":"1113569095","title":"雅各臣科研制药(02633)授予董事股份购回授权，规模达已发行股本10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1113569095","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113569095?lang=zh_cn&edition=full","pubTime":"2026-07-16 20:36","pubTimestamp":1784205383,"startTime":"0","endTime":"0","summary":"雅各臣科研制药公告显示，公司将于2026年8月11日（星期二）上午10时以线上虚拟方式召开股东周年大会，审议并授权董事于适当情况下可在香港联合交易所有限公司的市场上回购不超过公司召开股东周年大会当日已发行股份总数10%的股份。基于2026年7月10日的公司已发行股份总数2,000,221,000股，上述授权规模相当于最多回购200,022,100股。股权登记截日为2026年9月10日，届时持有公司股份的股东将有资格收取末期股息。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"雅各臣科研制药(02633)授予董事股份购回授权，规模达已发行股本10%","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103176166","title":"雅各臣科研制药（02633）公布2026年股东周年大会安排 拟派末期股息每股4.75港仙","url":"https://stock-news.laohu8.com/highlight/detail?id=1103176166","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103176166?lang=zh_cn&edition=full","pubTime":"2026-07-16 20:35","pubTimestamp":1784205356,"startTime":"0","endTime":"0","summary":"7月17日，雅各臣科研制药有限公司发布股东周年大会通告，宣布将于2026年8月11日上午10时通过虚拟会议形式召开股东周年大会。会议将使用Vistra卓佳电子投票系统，股东可线上参与、实时提问并行使投票权。以下为会议主要议程及相关安排：。– 宣派截至2026年3月31日止年度末期股息，每股4.75港仙。公司提醒股东关注恶劣天气下的会议安排，具体信息将于香港交易所及公司网站公布。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175176756","title":"雅各臣科研制药6月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1175176756","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175176756?lang=zh_cn&edition=full","pubTime":"2026-07-02 12:01","pubTimestamp":1782964893,"startTime":"0","endTime":"0","summary":"雅各臣科研制药（股票代码：02633）于2026年7月2日发布了截至2026年6月30日的股份变动月报表。公告显示，公司于本月未有新增股份发行、回购或注销行为，股本结构保持稳定。\n公司注册股本维持在5,000,000,000股，面值每股0.01港元，总额50,000,000港元。期末已发行股份（不包括库存股份）仍为2,000,221,000股，库存股份为0股，已发行股份总数维持2,000,221,000股。\n报告期内，公司未发生股份期权行使、购回或其他形式的股权变动。根据公告，公司确认已遵守相关上市规则及法律规定。该公告由公司秘书余振球签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647712103","title":"健倍苗苗(02161)拟7470万港元向雅各臣科研制药(02633)收购李众胜堂(集团)24.9%权益","url":"https://stock-news.laohu8.com/highlight/detail?id=2647712103","media":"智通财经","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647712103?lang=zh_cn&edition=full","pubTime":"2026-06-29 20:33","pubTimestamp":1782736423,"startTime":"0","endTime":"0","summary":"智通财经APP讯，健倍苗苗 及雅各臣科研制药联合公布，于2026年6月29日，雅各臣科研制药间接全资附属欧化药业拟向健倍苗苗间接全资附属Po Chai Herbal出售李众胜堂(集团)有限公司12.45万股份，总代价为7470万港元。公告称，该交易将令健倍苗苗巩固其对目标公司的控制权及策略方向。向健倍苗苗出售销售股份可让雅各臣变现对目标公司投资的财务收益，将非控制股权转化为流动资金。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1460599.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1606","BK1191","02161","02633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645835563","title":"雅各臣科研制药(02633)发布年度业绩，股东应占溢利3.02亿港元 同比增加0.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645835563","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645835563?lang=zh_cn&edition=full","pubTime":"2026-06-23 19:48","pubTimestamp":1782215298,"startTime":"0","endTime":"0","summary":"智通财经APP讯，雅各臣科研制药 发布截至2026年3月31日止年度业绩，该集团取得收益15.69亿港元，同比减少0.47%;公司权益持有人应占溢利3.02亿港元，同比增加0.26%;每股盈利15.1港仙，拟派发末期股息每股4.75港仙。尽管年内收益轻微回落，本集团仍取得本公司权益持有人应占溢利增长，反映我们核心业务所展现的稳健韧性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1457688.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146290127","title":"雅各臣科研制药建议派发末期股息每股0.0475港元，待股东大会批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1146290127","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146290127?lang=zh_cn&edition=full","pubTime":"2026-06-23 19:46","pubTimestamp":1782215179,"startTime":"0","endTime":"0","summary":"雅各臣科研制药(02633)于2026年6月23日发布公告，建议就截至2026年3月31日止年度派发末期普通股息，每股0.0475港元。该分派方案尚需在2026年8月11日举行的股东周年大会上获得批准。\n若股息获通过，关键日期如下：除净日为2026年9月7日，股东须于2026年9月8日下午4时30分前递交股份过户文件，以符合获取股息资格。公司将于2026年9月9日至10日暂停办理股份过户登记手续，权益登记日定于2026年9月10日。股息预计于2026年10月5日派发。\n公告明确，本次股息不涉及代扣所得税。股份过户登记由卓佳证券登记有限公司处理，地址为香港夏慤道16号远东金融中心17楼。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"雅各臣科研制药建议派发末期股息每股0.0475港元，待股东大会批准","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645835582","title":"雅各臣科研制药(02633)将于10月5日派发末期股息每股0.0475港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2645835582","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645835582?lang=zh_cn&edition=full","pubTime":"2026-06-23 19:45","pubTimestamp":1782215122,"startTime":"0","endTime":"0","summary":"智通财经APP讯，雅各臣科研制药(02633)发布公告，该公司将于2026年10月5日派发末期股息每股0.0475港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1457686.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02633","EWH","BK4585","VIG","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645884981","title":"雅各臣科研制药(02633)：杨俊文退任独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2645884981","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645884981?lang=zh_cn&edition=full","pubTime":"2026-06-23 16:58","pubTimestamp":1782205083,"startTime":"0","endTime":"0","summary":"智通财经APP讯，雅各臣科研制药(02633)发布公告，杨俊文先生将于2026年8月11日举行的公司应届股东周年大会结束时退任公司独立非执行董事一职。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1457494.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02633","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641193226","title":"雅各臣科研制药(02633.HK)拟6月23日举行董事会会议审批全年业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2641193226","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641193226?lang=zh_cn&edition=full","pubTime":"2026-06-05 08:17","pubTimestamp":1780618623,"startTime":"0","endTime":"0","summary":"格隆汇6月5日丨雅各臣科研制药(02633.HK)发布公告，谨定于2026年6月23日(星期二)举行董事会会议，藉以考虑及通过公司及其附属公司截至2026年3月31日止的年度全年业绩以供发布，并考虑建议派发末期股息(如有)，以及处理其他事项。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260605/32270724.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1191","02633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162736477","title":"雅各臣科研制药更新2026年5月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1162736477","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162736477?lang=zh_cn&edition=full","pubTime":"2026-06-01 15:22","pubTimestamp":1780298551,"startTime":"0","endTime":"0","summary":"雅各臣科研制药于2026年6月1日发布截至2026年5月31日的股份变动月报表。公告显示，公司注册股本维持在5,000,000,000股，面值每股HKD 0.01，总额HKD 50,000,000；当月并无任何新增发行、购回或注销股份。根据月报披露，截至2026年5月31日，已发行普通股股数为2,000,221,000股，与上期持平。公司亦确认其已符合相关公众持股量要求，期内未发生违反香港联合交易所有限公司上市规则的情况。公司在公告中表示已遵守香港联交所《上市规则》及适用法律法规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195407493","title":"雅各臣科研制药4月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1195407493","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195407493?lang=zh_cn&edition=full","pubTime":"2026-05-04 11:55","pubTimestamp":1777866933,"startTime":"0","endTime":"0","summary":"雅各臣科研制药有限公司于2026年5月4日发布截至2026年4月30日的股份变动月报表。报告显示，公司在本报告期内未进行新增股份的发行、购回或注销活动，整体股本维持稳定。根据公告，雅各臣科研制药确认，公司已遵循香港联合交易所有限公司《上市规则》及相关法律法规，并完成了本月涉及的所有可能发生的发行、库存出售或转让审批。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624139655","title":"雅各臣科研制药(02633)：委任承建商推进大埔创新园基建工程","url":"https://stock-news.laohu8.com/highlight/detail?id=2624139655","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624139655?lang=zh_cn&edition=full","pubTime":"2026-04-01 20:00","pubTimestamp":1775044859,"startTime":"0","endTime":"0","summary":"智通财经APP讯，雅各臣科研制药 发布公告，于2026年4月1日，代表公司间接全资附属公司正美药品行事的顾问，签立接纳函以确认承建商就于大埔厂房提供特定基建发展及专项设施工程所提交的投标，合约总额为6.072亿港元。于2025年，正美药品收购位于中国香港新界大埔大埔工业邨大喜街7号的专用制药设施大埔厂房。在策略方面，此举巩固公司在制药业的领先地位，并符合香港成为先进工业枢纽的愿景。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424173.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["165525","399995","02633","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154523461","title":"雅各臣科研旗下正美药品6.07亿元大埔厂房基建项目敲定承建商","url":"https://stock-news.laohu8.com/highlight/detail?id=1154523461","media":"公告速递","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154523461?lang=zh_cn&edition=full","pubTime":"2026-04-01 19:52","pubTimestamp":1775044351,"startTime":"0","endTime":"0","summary":"雅各臣科研制药公布，间接全资附属公司正美药品就大埔工业邨厂房的特定基建发展及专项设施工程已确定承建商，并于2026年4月1日签署具法律约束力的接纳函，合同总额为6.07亿元。此外，承建商须在接纳函日起一个月内提交相当于合同金额10%、即约0.61亿元的履约保证金。\\n\\n正美药品于2025年收购的大埔厂房计划建设10条智能制药生产线，涵盖无菌眼药水、固体剂型和口服液药物。本次基建工程将成为集团推进专用药及智能制造战略的关键环节。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162270669","title":"雅各臣科研制药3月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1162270669","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162270669?lang=zh_cn&edition=full","pubTime":"2026-04-01 11:50","pubTimestamp":1775015444,"startTime":"0","endTime":"0","summary":"雅各臣科研制药（股票代码：02633）于2026年4月1日发布2026年3月股份变动月报表。公告显示，该公司本月并未进行新增股份发行、购回或注销，股本维持稳定。\n注册股本方面，截至3月底，公司法定注册资本为港币50,000,000，股份面值为港币0.01，股本总数维持5,000,000,000股，与上月底一致。已发行股份数量为2,000,221,000股，未有新变动或增减。\n期权及相关激励计划方面，公告披露本月内无期权行使、失效或授出；无其他类型股份或库藏股变动行为。\n公司表示已遵守香港联交所《上市规则》及适用法规，所有相关审批及存档程序均已完成。本次公告由公司秘书余振球签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616155540","title":"雅各臣科研制药03月04日主力净流出26.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2616155540","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616155540?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:15","pubTimestamp":1772612128,"startTime":"0","endTime":"0","summary":"03月04日，雅各臣科研制药股价收平报1.26元，成交金额45.3万元，换手率0.02%，振幅0.79%，量比1.31。雅各臣科研制药今日主力资金净流出26.5万元，上一交易日主力净流出0万元。该股近5个交易日下跌0.79%，主力资金累计净流出26.5万元；近20日主力资金累计净流出26.5万元，其中净流出天数为1日。该股主力净额占比0.01%，港股市场排名2393/2716。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304161642a44a5985&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304161642a44a5985&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127490589","title":"雅各臣科研製藥（02633）2026年2月股份变动月报：股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1127490589","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127490589?lang=zh_cn&edition=full","pubTime":"2026-03-02 13:41","pubTimestamp":1772430119,"startTime":"0","endTime":"0","summary":"雅各臣科研製藥有限公司于2026年3月2日发布截至2026年2月28日的股份变动月报。报告显示，公司本月未有新增发行、购回或注销股份，各项股本情况保持不变。截至2月底，已发行普通股股份数为2,000,221,000股，与上月保持一致，未有库藏股份变动。公司同时确认截至2月底符合香港联交所相关上市规则的公众持股量要求。公告由公司秘书余振球签署。整体来看，公司本月股本结构维持稳定，未发生实质性变动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163035342","title":"雅各臣科研製藥（02633）2026年1月股份變動月報：股本維持不變","url":"https://stock-news.laohu8.com/highlight/detail?id=1163035342","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163035342?lang=zh_cn&edition=full","pubTime":"2026-02-02 11:05","pubTimestamp":1770001519,"startTime":"0","endTime":"0","summary":"2026年2月2日，雅各臣科研製藥有限公司公佈2026年1月股份變動月報。公告顯示，截至1月31日，公司已發行及註冊股本保持穩定，當月並無新增發行、購回或註銷股份。截至本月底，公司已發行股份總數為2,000,221,000股，無庫存股份，與上月底一致。公司同時確認本月公眾持股量符合香港聯交所相關規定。公司表示，在報告期內嚴格遵守香港聯交所《上市規則》及其他相關法律法規。本次月報由公司秘書余振球簽署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517360411","title":"雅各臣科研制药03月06日主力净流出57万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2517360411","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517360411?lang=zh_cn&edition=full","pubTime":"2025-03-06 16:17","pubTimestamp":1741249067,"startTime":"0","endTime":"0","summary":"03月06日, 雅各臣科研制药股价跌1.64%，报收1.20元，成交金额256万元，换手率0.11%，振幅1.64%，量比2.31。雅各臣科研制药今日主力资金净流出57万元，上一交易日主力净流出0万元。该股近5个交易日下跌0.83%，主力资金累计净流出57万元；近20日主力资金累计净流入199万元，其中净流入天数为4日。该股主力净额占比0.02%，港股市场排名2473/2651。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306170532abeb1727&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306170532abeb1727&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514968193","title":"雅各臣科研制药：欧化药业与李众胜堂订立2025年许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2514968193","media":"新浪港股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514968193?lang=zh_cn&edition=full","pubTime":"2025-02-28 12:46","pubTimestamp":1740717960,"startTime":"0","endTime":"0","summary":"　　雅各臣科研制药及健倍苗苗联合公布，于2025年2月28日，欧化药业与李众胜堂订立 2025年许可协议，据此，欧化药业同意根据 2025年许可协议的条款及条件许可李众胜堂使用部分工厂，年期自 2025年1月 28日起至 2028年 1月27日止，每月许可费为21.8万港元。　　健倍苗苗非执行董事、主席兼控股股东岑先生于雅各臣已发行股份中拥有约59.92%权益，而欧化药业为雅各臣的间接全资附属公司。因此，欧化药业为岑先生的联系人及健倍苗苗的关 联人士。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-02-28/doc-inemzcmp5743042.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1585","BK1201","02633","BK1191","01711"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514339597","title":"雅各臣科研制药(02633)：欧化药业与李众胜堂订立2025年许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2514339597","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514339597?lang=zh_cn&edition=full","pubTime":"2025-02-28 12:29","pubTimestamp":1740716990,"startTime":"0","endTime":"0","summary":"智通财经APP讯，雅各臣科研制药(02633)及健倍苗苗(02161)联合公布，于2025年2月28日，欧化药业与李众胜堂订立 2025年许可协议，据此，欧化药业同意根据 2025年许可协议的条款及条件许可李众胜堂使用部分工厂，年期自 2025年1月 28日起至 2028年 1月27日止(包括首尾两日)，每月许可费为21.8万港元。健倍苗苗非执行董事、主席兼控股股东岑先生于雅各臣已发行股份中拥有约59.92%权益，而欧化药业为雅各臣的间接全资附属公司。因此，欧化药业为岑先生的联系人及健倍苗苗的关 联人士。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1256001.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02633","01711","BK1201","BK1585"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.jacobsonpharma.com","stockEarnings":[{"period":"1week","weight":-0.0093},{"period":"1month","weight":-0.0183},{"period":"3month","weight":-0.0696},{"period":"6month","weight":-0.144},{"period":"1year","weight":-0.2804},{"period":"ytd","weight":-0.1769}],"compareEarnings":[{"period":"1week","weight":0.0384},{"period":"1month","weight":0.0509},{"period":"3month","weight":-0.0508},{"period":"6month","weight":-0.0542},{"period":"1year","weight":0.0128},{"period":"ytd","weight":-0.019}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"雅各臣科研制药有限公司是一家从事非专利药制造及销售投资控股公司。该公司通过两大分部运营。非专利药分部从事开发、制造及分销一系列具有不同疗效的非专利药物。品牌医疗保健分部从事开发、制造分销品牌药、品牌中药及健康保健品。现时两个分部有关此方面的业务主要在香港进行。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.007288},{"month":2,"riseRate":0.3,"avgChangeRate":0.008406},{"month":3,"riseRate":0.2,"avgChangeRate":-0.059243},{"month":4,"riseRate":0.4,"avgChangeRate":-0.021628},{"month":5,"riseRate":0.7,"avgChangeRate":0.012273},{"month":6,"riseRate":0.6,"avgChangeRate":0.043499},{"month":7,"riseRate":0.4,"avgChangeRate":-0.029605},{"month":8,"riseRate":0.555556,"avgChangeRate":0.017343},{"month":9,"riseRate":0.222222,"avgChangeRate":-0.010618},{"month":10,"riseRate":0.1,"avgChangeRate":-0.049312},{"month":11,"riseRate":0.5,"avgChangeRate":0.037928},{"month":12,"riseRate":0.9,"avgChangeRate":0.124019}],"exchange":"SEHK","name":"雅各臣科研制药","nameEN":"JACOBSON PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"雅各臣科研制药(02633)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供雅各臣科研制药(02633)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"雅各臣科研制药,02633,雅各臣科研制药股票,雅各臣科研制药股票老虎,雅各臣科研制药股票老虎国际,雅各臣科研制药行情,雅各臣科研制药股票行情,雅各臣科研制药股价,雅各臣科研制药股市,雅各臣科研制药股票价格,雅各臣科研制药股票交易,雅各臣科研制药股票购买,雅各臣科研制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"雅各臣科研制药(02633)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供雅各臣科研制药(02633)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}